Literature DB >> 18488055

Does increased levetiracetam clearance during pregnancy require planned intervention?

Bassel W Abou-Khalil.   

Abstract

Entities:  

Year:  2008        PMID： 18488055      PMCID： PMC2384150          DOI： 10.1111/j.1535-7511.2008.00238.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  13 in total

1.  Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.

Authors:  F J E Vajda; A Hitchcock; J Graham; C Solinas; T J O'Brien; C M Lander; M J Eadie
Journal:  Eur J Neurol       Date:  2006-06       Impact factor: 6.089

2.  Valproate effects on kinetics of lamotrigine in pregnancy and treatment with oral contraceptives.

Authors:  T Tomson; G Luef; A Sabers; S Pittschieler; I Ohman
Journal:  Neurology       Date:  2006-10-10       Impact factor: 9.910

3.  Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation.

Authors:  Torbjörn Tomson; Ragnar Palm; Kristina Källén; Elinor Ben-Menachem; Birgitta Söderfeldt; Bo Danielsson; Rune Johansson; Gerhard Luef; Inger Ohman
Journal:  Epilepsia       Date:  2007-03-22       Impact factor: 5.864

4.  Levetiracetam in pregnancy: preliminary experience from the UK Epilepsy and Pregnancy Register.

Authors:  S Hunt; J Craig; A Russell; E Guthrie; L Parsons; I Robertson; R Waddell; B Irwin; P J Morrison; J Morrow
Journal:  Neurology       Date:  2006-11-28       Impact factor: 9.910

5.  Seizure control and treatment in pregnancy: observations from the EURAP epilepsy pregnancy registry.

Authors: 
Journal:  Neurology       Date:  2005-12-28       Impact factor: 9.910

6.  Levetiracetam concentrations in serum and in breast milk at birth and during lactation.

Authors:  Svein I Johannessen; Grethe Helde; Eylert Brodtkorb
Journal:  Epilepsia       Date:  2005-05       Impact factor: 5.864

7.  Plasma concentrations of lamotrigine and its 2-N-glucuronide metabolite during pregnancy in women with epilepsy.

Authors:  Inger Ohman; Olof Beck; Sigurd Vitols; Torbjörn Tomson
Journal:  Epilepsia       Date:  2007-12-11       Impact factor: 5.864

8.  Gestation-induced changes in lamotrigine pharmacokinetics: a monotherapy study.

Authors:  G-J de Haan; P Edelbroek; J Segers; M Engelsman; D Lindhout; M Dévilé-Notschaele; P Augustijn
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

9.  Changes in the disposition of oxcarbazepine and its metabolites during pregnancy and the puerperium.

Authors:  Iolanda Mazzucchelli; Filiz Yilmaz Onat; Cigdem Ozkara; Dilek Atakli; Luigi M Specchio; Angela La Neve; Giuliana Gatti; Emilio Perucca
Journal:  Epilepsia       Date:  2006-03       Impact factor: 5.864

10.  Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Authors:  P B Pennell; L Peng; D J Newport; J C Ritchie; A Koganti; D K Holley; M Newman; Z N Stowe
Journal:  Neurology       Date:  2007-11-28       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.